The OnKure team is comprised of proven drug discovery and development scientists who are combining their cancer biology, medicinal chemistry and development expertise to create a robust pipeline of new candidates. Our leadership team made significant contributions to the success of several drug discovery companies, resulting in more than ten new approved drugs. Our drug discovery and development acumen positions us well to write the next chapter in oncology precision medicines.

30+ INDs accepted collectively

Management team members have a combined average of 25 years of experience

6 breakthrough precision medicines on the market to date, with others in registration trials